Alternate Day Versus Daily Oral Iron Therapy in Adolescents
Launched by BAYLOR COLLEGE OF MEDICINE · Aug 16, 2021
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The research will be conducted at the following location(s):
Baylor College of Medicine, TCH: Texas Children's Hospital, and TCH: Texas Children's Hospital Clinic.
If patient appears to qualify for the study they will sign and date this consent form, and the doctor will confirm that they are eligible for the study. The patient will complete the following procedures:
* Medical history including prior hospitalizations, lab results, medications, diet, social and family history
* Physical Examination
* Blood samples: The patient will not have any extra blood draws (pokes) for this study. How...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 9 years or greater and less than age 22 years
- • 2. Heavy menstrual bleeding, defined as a Pictorial Blood Assessment Chart (PBAC) Score \>100
- • 3. Iron deficiency anemia, defined as both hemoglobin \<12 g/dL and ferritin \<15 ng/mL within 7 days of enrollment.
- Exclusion Criteria:
- • 1. non-uterine cause of vaginal bleeding
- • 2. pregnancy
- • 3. chronic kidney disease
- • 4. serology confirmed celiac disease
- • 5. active gastrointestinal blood loss
- • 6. active malignancy
- • 7. inability to follow-up at Texas Children's Hospital
- • 8. receipt of intravenous iron within 30 days prior to enrollment
- • 9. allergy or known inability to tolerate oral iron
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Jacquelyn Powers, MD
Principal Investigator
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials